| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,303 |
2,835 |
$53K |
| 99215 |
Prolong outpt/office vis |
1,375 |
559 |
$20K |
| 99497 |
|
1,491 |
604 |
$13K |
| 99490 |
Ccm add 20min |
3,218 |
2,461 |
$7K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,605 |
1,168 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,162 |
470 |
$3K |
| 93000 |
|
1,112 |
417 |
$2K |
| 94010 |
|
209 |
163 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
821 |
353 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
4,773 |
2,382 |
$2K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
1,274 |
503 |
$2K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,517 |
607 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
52 |
19 |
$1K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,380 |
573 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
93 |
55 |
$840.02 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
30 |
14 |
$753.06 |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
361 |
138 |
$510.14 |
| 99457 |
|
796 |
561 |
$450.18 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
761 |
280 |
$449.99 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
630 |
201 |
$428.17 |
| 99458 |
|
455 |
332 |
$401.28 |
| 71046 |
Radiologic examination, chest; 2 views |
297 |
107 |
$386.55 |
| 80061 |
Lipid panel |
913 |
424 |
$377.78 |
| 82947 |
|
1,168 |
462 |
$329.55 |
| 3078F |
|
3,173 |
1,808 |
$319.41 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
726 |
316 |
$294.75 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
127 |
52 |
$265.41 |
| 99406 |
|
463 |
181 |
$262.26 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
179 |
97 |
$240.97 |
| 3074F |
|
3,065 |
1,761 |
$240.35 |
| 80053 |
Comprehensive metabolic panel |
1,120 |
535 |
$236.46 |
| 94060 |
|
30 |
13 |
$226.88 |
| 3079F |
|
1,599 |
875 |
$211.01 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
59 |
29 |
$179.78 |
| 3075F |
|
1,413 |
728 |
$170.05 |
| 84443 |
Thyroid stimulating hormone (TSH) |
431 |
179 |
$118.49 |
| 81003 |
|
423 |
202 |
$111.96 |
| 3077F |
|
406 |
240 |
$110.00 |
| 82728 |
|
79 |
27 |
$102.24 |
| 84439 |
|
438 |
170 |
$97.68 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
35 |
25 |
$83.12 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
199 |
74 |
$80.96 |
| 96160 |
|
151 |
54 |
$47.69 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
455 |
213 |
$41.85 |
| 82043 |
|
296 |
119 |
$35.64 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
77 |
52 |
$31.58 |
| 92250 |
|
42 |
15 |
$31.32 |
| G0443 |
Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes |
48 |
20 |
$24.68 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
12 |
$19.88 |
| 82570 |
|
51 |
24 |
$19.42 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
144 |
66 |
$17.31 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
430 |
195 |
$16.12 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
19 |
12 |
$9.01 |
| 36416 |
|
324 |
100 |
$6.70 |
| 85027 |
|
131 |
83 |
$6.09 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
32 |
14 |
$3.15 |
| 96127 |
|
62 |
19 |
$0.77 |
| V5008 |
Hearing screening |
94 |
39 |
$0.05 |
| 1170F |
|
1,131 |
575 |
$0.02 |
| 1126F |
|
1,044 |
538 |
$0.02 |
| 1003F |
|
1,174 |
552 |
$0.02 |
| 1160F |
|
3,741 |
1,950 |
$0.02 |
| 1158F |
|
1,143 |
569 |
$0.02 |
| 1159F |
|
3,688 |
1,942 |
$0.02 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,064 |
612 |
$0.01 |
| 2000F |
|
90 |
23 |
$0.00 |
| 1000F |
|
580 |
265 |
$0.00 |
| 3008F |
|
3,870 |
2,008 |
$0.00 |
| 4010F |
|
935 |
482 |
$0.00 |
| 3044F |
|
600 |
278 |
$0.00 |
| 99454 |
|
96 |
53 |
$0.00 |
| 3049F |
|
451 |
220 |
$0.00 |
| 3080F |
|
129 |
61 |
$0.00 |
| 3048F |
|
924 |
445 |
$0.00 |
| 94760 |
|
21 |
19 |
$0.00 |
| 81001 |
|
34 |
14 |
$0.00 |
| 84436 |
|
44 |
15 |
$0.00 |
| 2019F |
|
57 |
25 |
$0.00 |
| 1111F |
|
53 |
30 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
18 |
12 |
$0.00 |
| 1036F |
|
71 |
37 |
$0.00 |
| 3061F |
|
32 |
17 |
$0.00 |
| 3017F |
|
44 |
13 |
$0.00 |
| 1125F |
|
15 |
12 |
$0.00 |
| G9189 |
Beta-blocker therapy prescribed or currently being taken |
52 |
28 |
$0.00 |
| G8866 |
Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal) |
26 |
15 |
$0.00 |
| 4008F |
|
145 |
63 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
94 |
53 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
25 |
16 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,406 |
1,182 |
$0.00 |
| 3288F |
|
718 |
316 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,233 |
2,201 |
$0.00 |
| 1090F |
|
705 |
307 |
$0.00 |
| 4013F |
|
317 |
155 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
48 |
24 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
203 |
108 |
$0.00 |
| 99499 |
|
510 |
345 |
$0.00 |
| 3755F |
|
13 |
12 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
221 |
125 |
$0.00 |
| 99080 |
|
1,198 |
165 |
$0.00 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
22 |
12 |
$0.00 |
| 1033F |
|
377 |
186 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
29 |
15 |
$0.00 |
| 3046F |
|
21 |
13 |
$0.00 |
| 4040F |
|
51 |
14 |
$0.00 |